Search Orphan Drug Designations and Approvals
-
Generic Name: | (1R,2R)-1,2-cyclohexane-diaminepyrophosphato-platinum(II) |
---|---|
Date Designated: | 10/25/2018 |
Orphan Designation: | Treatment of thymoma and thymic carcinoma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Promontory Therapeutics, Inc. 1350 6th Avenue 3rd Floor New York, New York 10019 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-